Endothelial cell culture of intramuscular venous malformation and its invasive behavior related to matrix metalloproteinase-9

Plastic and Reconstructive Surgery

Volumn 123, Issue 5, 2009, Pages 1419-1430

  Wang, Yan ^a   Qi, Fazhi ^a   Gu, Jianying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MESSENGER RNA;

ADULT; ARTICLE; CELL CULTURE; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VEIN MALFORMATION; ARTERIOVENOUS MALFORMATION; BIOSYNTHESIS; CONGENITAL MALFORMATION; CULTURE TECHNIQUE; METABOLISM; SKELETAL MUSCLE; VASCULARIZATION; VEIN;

ADULT; ARTERIOVENOUS MALFORMATIONS; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MUSCLE, SKELETAL; VEINS; YOUNG ADULT;

EID: 66549104977     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181a073eb     Document Type: Article

References (35)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations of infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412- 422.
2. Breugem MB, Maas M, Reekers JR, van der Horst CM. Use of magnetic resonance imaging for the evaluation of vascular malformations of the lower extremity. Plast Reconstr Surg. 2001;108:870-877.
3. Wild AT, Raab P, Krauspe R. Hemangioma of skeletal muscle. Arch Orthop Trauma Surg. 2000;120:139-143.
4. Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000;31: 462-471.
5. Hein KD, Mulliken JB, Kozakewich HPW, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110:1625-1635.
6. Rautio R, Saarinen J, Laranne J, Salenius JP, Keski-Nisula L. Endovascular treatment of venous malformations in extremities: Results of sclerotherapy and the quality of life after treatment. Acta Radiol. 2004;45:397-403.
7. Timur AA, Driscollc DJ, Wang Q. Biomedicine and diseases: The Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci. 2005;62:1434-1447.
8. Shireman PK, McCarthy WJ, Yao JS, Vogelzang RL. Treatment of venous malformations by direct injection with ethanol. J Vasc Surg. 1997;26:838-844.
9. Thorin E, Shatos MA, Shreeve SM, Walters CL, Bevan JA. Human vascular endothelium heterogeneity: A comparative study of cerebral and peripheral cultured vascular endothelial cells. Stroke 1997;28:375-381.
10. Blebea J, VuJH, AssadniaS, McLaughlin PJ, Atnip RG, Zagon IS. Differential effects of vascular growth factors on arterial and venous angiogenesis. J Vasc Surg. 2002;35:532-538.
11. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hem-angiomas. J Clin Invest. 2001;107:745-752.
12. Tan ST, Hasan Q, Velickovic M, Rüger BM, Davis RP, Davis PF. A novel in vitro human model of hemangioma. Mod Pathol. 2000;13:92-99.
13. Ema M, YokomizoT, Wakamatsu A, TerunumaT, Yamamoto M, Takahashi S. Primitive erythropoiesis from mesodermal precursors expressing VE-cadherin, PECAM-1, Tie2, endog-lin, and CD34 in the mouse embryo. Blood 2006;108:4018- 4024.
14. Tille JC, Pepper MS. Hereditary vascular anomalies: New insights into their pathogenesis. Arterioscler Thromb Vasc Biol. 2004;24:1578-1590.
15. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997;81:567-574.
16. Vikkula M, Boon LM, Carraway KL, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-1190.
17. Wang H, Zh Y, Toratani S, Okamoto T. Transformation of vascular endothelial cells by a point mutation in the Tie2 gene from human intramuscular haemangioma. Oncogene 2004;23:8700-8704.
18. Takahashi K, Mulliken JB, Harry PW, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phase of hemangioma during infancy and childhood. J Clin Invest. 1994;93:2357-2364.
19. KleinG,VellengaE,Fraaije MW, Kamps WA,deBont ES. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol. 2004;50:87-100.
20. Marler JJ, Fishman SJ, Kilroy SM, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics 2005;116:38-45.
21. Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 2003;34:925-931.
22. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52:2745-2756.
23. Liang CC, Park AY, Guan JL. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329-333.
24. Quinn PS, Sieunarine K, Lawrence-Brown M, Tan P. Intramuscular haemangiomas: Hookwire localization prior to surgical excision: Report of four cases. ANZ J Surg. 2001;71:62-66.
25. Wang DF, Lehman RE, Donner DB, Matli MR, Warren RS, Welton ML. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. Am J Physiol. 2002;282:G1088-G1096.
26. Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 2000;102:75-81.
27. Morris PN, Dunmore BJ, Tadros A, et al. Functional analysis of amutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med. 2005;83:58-63.
28. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007;1773:642-652.
29. Fletcher BC. Intramuscular angioma: A clinicopathological analysis of 74 cases. Histopathology 1991;18:53-59.
30. Jochen AW, Anja-A DB, Folz RRJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol. 2001;258:141-149.
31. Fayad L, Hazirolan T, Bluemke D, Mitchell S. Vascular malformations in the extremities: Emphasis on MR imaging features that guide treatment options. Skel Radiol. 2006;35: 127-137.
32. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9:267-285.
33. Godin D, Ivan E, Johnson C, Magid R, Galis ZS. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000;102:2861-2866.
34. deNooijerR,Verkleij CJN, von der Thüsen JH, etal. Lesional overexpression of matrix metalloproteinase-9 promotes in-traplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol. 2006;26: 340-346.
35. Allen PW, Enzinger FM. Hemangioma of skeletal muscle: An analysis of 89 cases. Cancer 1972;29:8-22.